Biggerstaff Brad J, Petersen Lyle R
Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80521, USA.
Transfusion. 2009 Jun;49(6):1151-9. doi: 10.1111/j.1537-2995.2009.02112.x. Epub 2009 Feb 27.
To decrease the likelihood of transmission from donations containing West Nile virus (WNV) levels below minipool nucleic acid test (MP-NAT) detection limits, blood centers switch from MP-NAT to individual-donation testing (ID-NAT) after detection of MP-NAT-positive donations. The effectiveness of strategies to trigger or discontinue ID-NAT screening is largely unknown.
Twenty-seven strategies to trigger and discontinue ID-NAT screening were evaluated with a statistical model based on known dynamics of WNV infection and historical data on WNV prevalence among blood donations. Breakthroughs were defined as WNV immunoglobulin M antibody-negative, viremic (RNA-positive) donations that could only be identified by ID-NAT, but were screened by MP-NAT. Effectiveness (proportional reduction of breakthroughs relative to MP-NAT screening alone) and efficiency (absolute reduction of breakthroughs relative to the number of tests performed) were estimated by simulating donation years of varying outbreak severities over a range of blood collection frequencies.
Most strategies were effective (>75% reduction in breakthroughs) when daily donations exceeded 560. In larger centers (1008 donations daily), effectiveness of trigger-on strategies based on absolute number of MP-NAT-positive donations improved, but worsened for strategies using rate-based criteria. Effectiveness increased slightly by triggering on one MP-NAT-positive rather than two and increased substantially by increasing the duration from 7 to 14 days that no ID-NAT-positive donations are detected before resuming MP-NAT.
Most trigger strategies become effective when test results from at least 560 donations daily are considered. A 14-day ID-NAT period may improve safety relative to the increase in the number of tests performed.
为降低含有低于微池核酸检测(MP-NAT)检测限的西尼罗河病毒(WNV)水平的献血传播风险,血液中心在检测到MP-NAT阳性献血后,会从MP-NAT检测切换至单份献血检测(ID-NAT)。触发或停止ID-NAT筛查策略的有效性在很大程度上尚不清楚。
基于WNV感染的已知动态和献血中WNV流行率的历史数据,用统计模型评估了27种触发和停止ID-NAT筛查的策略。突破定义为仅通过ID-NAT才能识别但经MP-NAT筛查的WNV免疫球蛋白M抗体阴性、病毒血症(RNA阳性)的献血。通过模拟不同爆发严重程度在一系列采血频率下的献血年份,估计有效性(相对于仅进行MP-NAT筛查时突破的比例降低)和效率(相对于进行的检测数量突破的绝对减少)。
当每日献血量超过560份时,大多数策略是有效的(突破减少>75%)。在较大的中心(每日1008份献血),基于MP-NAT阳性献血绝对数量的触发策略的有效性提高,但基于比率标准的策略有效性变差。通过触发一份而非两份MP-NAT阳性献血,有效性略有增加;通过将在恢复MP-NAT之前未检测到ID-NAT阳性献血的持续时间从7天增加到14天,有效性大幅增加。
当考虑每日至少560份献血的检测结果时,大多数触发策略变得有效。相对于检测数量的增加,14天的ID-NAT检测期可能会提高安全性。